ライフサイエンスコーパス: stoma

1 2.10; 95% CI, 1.86 to 2.36 compared with no stoma).

2 g-term quality of life and risk of permanent stoma.

3 cribe any continent catheterizable abdominal stoma.

4 pic group and 11 in the Hartmann group had a stoma.

5 rate problems than those who had never had a stoma.

6 adaptation to and acceptance of self-with-a-stoma.

7 coloanal anastomosis and without a diverting stoma.

8 on, around 17% of patients remain with their stoma.

9 s a functional anastomosis without diverting stoma.

10 Sixty-two percent had a temporary diverting stoma.

11 ctal margin in hopes of avoiding a permanent stoma.

12 ncluded prolapse and infections of the graft stoma.

13 to increase outlet resistance, and continent stomas.

14 higher incidence of AL than those without a stoma (15.97% vs 13.25%).

15 Of respondents without a stoma, 16.3% reported no bowel control.

16 Sixteen of 677 with defunctioning stoma (2.2%) developed clinical leak; 24 of 450 without

17 2 vs 50.4% LC, p = 0.68), although permanent stoma (38.0% vs 29.8%, P = 0.13) and anastomotic breakdo

18 total of 286 procedures (132 with associated stoma, 46%) were performed including 217 conservative (7

19 ) developed clinical leak; 24 of 450 without stoma (6.3%) developed leak (P = 0.005).

20 ent of RVF, including early use of temporary stoma and major procedure in case of failure of previous

21 interacts with future avoidance of permanent stoma and quality of life (QoL) is studied.

22 ce to solid stool for patients with baseline stomas and for patients undergoing total anal reconstruc

23 the patients had closure of their diverting stomas and maintained healed rectourethral fistulas.

24 d peritonitis, coagulopathy, age, the use of stoma, and chronic kidney disease as strong predictors o

25 e, surgical site, postoperative comorbidity, stoma, and nasogastric tube) with LRD patients having an

26 ance of tumor from anal verge, defunctioning stoma, and pathologic stage, clinical leak was not assoc

27 eveloping soybean embryos do not form mature stoma, and stomatal differentiation is arrested at the g

28 th active or recurrent disease, those with a stoma, and those at the extremes of the age range (< 55

29 group 2, >/=50% colon-in-continuity without stoma; and group 3, other colon anatomies), and disease

30 The two guard cells of a stoma are produced by a single symmetric division just b

31 how individuals experience living with a new stoma but little is known of the individual experience o

32 Intestinal stomas can pose significant challenges for long-term (>

33 nence and one patient had not had a covering stoma closed.

34 al stay (12.2 vs 12.2; P = 0.99) and rate of stoma closure (80.1% vs 77.3%; P = 0.53) between groups.

35 tly higher percentage of formed stools after stoma closure (P=0.001).

36 ration, length of hospital stay, and rate of stoma closure at 6 months.

37 my for rejection) and accepted or quiescent (stoma closure in stable transplant recipients) grafts we

38 the time of any operative resection, such as stoma closure or revision.

39 One patient declined stoma closure.

40 exner Fecal Incontinence Questionnaire after stoma closure.

41 leakage of the small bowel anastomosis after stoma closure.

42 ith early closure (8-13 days) of a temporary stoma compared with standard procedure (closure after >

43 ioperative transfusion (OR: 1.6, P < 0.010), stoma constructed (OR: 1.4, P < 0.001), and operation la

44 At 4.5 years, 7/11 patients had avoided stoma construction.

45 orectal cancer and who underwent stenting or stoma creation from October 1, 2009, through December 31

46 ompare outcomes after palliative stenting vs stoma creation in patients with MLBO requiring emergency

47 Early closure (8-13 days after stoma creation) of a temporary ileostomy was compared wi

48 orrelated with the requirement for permanent stoma creation, while only free anastomotic leak was ass

49 Palliative stenting vs stoma creation.

50 Exclusion criteria included postoperative stoma, emergent or urgent operation, and diagnosis of in

51 potential to reduce the need for a permanent stoma even further than is currently the case.

52 Patients with a stoma, fistula, or soft-tissue infection were excluded.

53 an independent risk factor for recurrence or stoma formation and no reduction in QoL scores to sugges

54 independent risk factors for recurrence and stoma formation identified.

55 Symptoms recurred leading to permanent stoma formation in 1 patient, whereas one other develope

56 or expression1/scream2 that are required for stoma formation in Arabidopsis.

57 y been treated with open colon resection and stoma formation with risk for reoperations, morbidity, a

58 aracteristics, operative details, morbidity, stoma formation, recurrence requiring surgery and QoL da

59 conventionally been managed by resection and stoma formation.

60 epair, with selective defunctioning proximal stoma formation.

61 c lavage, resulting in reduced mortality and stoma formation.

62 PSH is the most frequent complication after stoma formation.

63 f healthcare experiences of people following stoma-forming surgery were identified: Relationships wit

64 others providing care for patients following stoma-forming surgery.

65 recurrence free survival (P = 0.032) but not stoma free survival P = 0.62 on univariate analysis.

66 Recurrence and stoma free survival was calculated for each group and in

67 ed by regaining physical capacity, mastering stoma function, purposeful care, and acceptance and supp

68 ing an operation, particularly the fear of a stoma, generated anxiety and concern for many of these y

69 nts (mean [SD] age, 69.9 [14.4] years in the stoma group and 70.9 [16.8] years in the stent group; 87

70 4 non-Hispanic white patients [65.9%] in the stoma group and 90 [52.3%] in the stent group).

71 rs in the stent group; 87 men [50.3%] in the stoma group and 90 [52.3%] in the stent group; and 114 n

72 oscopic and open resections with a diverting stoma had a higher incidence of AL than those without a

73 d with surgery including colon resection and stoma (Hartmann procedure) with considerable postoperati

74 Careful patient selection for defunctioning stoma helps reduce risk of clinically significant anasto

75 lavage was compared with colon resection and stoma in a randomized controlled multicenter trial, DILA

76 s paralogs are required for the formation of stoma in leaves and stomatal precursor complexes in matu

77 The vaginal vault was exteriorized as a stoma in the lower right abdominal wall.

78 y 102,000 individuals live with an excretory stoma in the UK.

79 RF reaching a 50-mum depth of chick corneal stoma increased dramatically after exposure to NC-1059 f

80 Relocation of the stoma may be associated with a new ulceration and should

81 Primary anastomosis with defunctioning stoma may be the optimal strategy for selected patients

82 can Society of Anesthesiologists) grade, and stoma moderated the impact of complications in the short

83 actors considered were the risk of permanent stoma, morbidity, and mortality from the primary or reve

84 uded the presence of infected mesh (n = 45), stoma (n = 24), concomitant gastrointestinal (GI) surger

85 g anesthesia (n=1), and complications of the stoma (n=2).

86 Data (age, gender, stage, defunctioning stoma, neoadjuvant treatment, distance from anal verge,

87 als, with a maximum of 3.7% recovered at the stoma of one individual.

88 reathing by the patient through the tracheal stoma, one would expect low levels of muscle activation

89 al advancement flap (n = 46; 16%), diverting stoma only (n = 27; 9%), plug (n = 15; 5%), glue (n = 13

90 ng the transplant recipients, 17 (85%) had a stoma or enterocutaneous fistula, and the mean (SD) resi

91 results when divisions next to a preexisting stoma or precursor are oriented so that the new meristem

92 morbidity index (OR 1.4 per point), and loop stoma (OR 2.2); longer length of stay (OR 0.5) and age 6

93 pared with being in remission), and having a stoma (OR, 2.10; 95% CI, 1.86 to 2.36 compared with no s

94 (OR): 6.4 (2.9-14.2); P < 0.001], diverting stoma [OR: 3.5 (1.4-8.7); P = 0.009], less than 9 months

95 , 126 primary anastomoses with defunctioning stoma (PADS), and 6619 Hartmann's procedures (HP) were c

96 uid and electrolyte disorders, male sex, and stoma placement independently increased the risk of leak

97 Stoma placement should be performed to best facilitate c

98 uid and electrolyte disorders, male sex, and stoma placement were associated with a higher risk of AL

99 A stoma provided a safe alternative but was only effective

100 There were clinical trends in permanent stoma rates and anastomotic leaks in favor of LC but wit

101 Unit admissions, 30 and 90-day mortality, or stoma rates at 12 months.

102 Stomas remained permanent in 27% of HP and in 8% of PADS

103 Reversal of a stoma resulted in fewer severe bowel problems but more m

104 Surgical site infection following stoma reversal (SR) poses a substantial burden to the pa

105 tanding of surgical site infection following stoma reversal may help us identify methods to decrease

106 diverting ileostomy, n = 32), with a planned stoma reversal operation after 3 months in both groups.

107 all complication rate for both resection and stoma reversal operations was comparable (80% vs 84%, P

108 % and morbidity 67% vs 75% in HP vs PA), the stoma reversal rate after PA with diverting ileostomy wa

109 astomotic complications (reoperation, rescue stoma, revision of an anastomosis, and percutaneous drai

110 ious complications, comorbidity burden, loop stoma, shorter length of stay, and age.

111 ive options using a catheterizable abdominal stoma should be discussed with patients with intractable

112 ed in the stroma surrounding CCH compared to stoma surrounding normal terminal duct lobular units (TD

113 When stratified for defunctioning stoma, there was no association between clinical leak an

114 and digesta are diverted from the body via a stoma to a colostomy bag).

115 of care that assists individuals with a new stoma to adapt to and accept a changed sense of embodied

116 Many have a defunctioning stoma to reduce risk of clinically significant leakage.

117 ness plications within the gastric pouch and stoma using the StomaphyX device with SerosFuse fastener

118 e control, hollow visceral injury (HVI), and stoma utilization.

119 l stenosis, the OR associated with permanent stoma was 33 (P = 0.0023).

120 Defunctioning stoma was associated with lower incidence of clinical le

121 er a median delay of 2.2 months (0.8-121.6), stoma was closed in 56 patients.

122 Consequently, optimal function per stoma was dependent on maintaining one epidermal cell sp

123 * Consequently, optimal function per stoma was dependent on maintaining one epidermal cell sp

124 The stoma was not closed in 4 of 456 (0.6%) patients.

125 Both patients whose stoma was relocated developed an ulcer at the new site.

126 p to 3 months after closure of the diverting stoma were graded according to the Dindo classification.

127 olon cancer with primary anastomosis without stoma, were included in a prospective online database (S